Paul W. Hoelscher - Jan 20, 2022 Form 3 Insider Report for Reneo Pharmaceuticals, Inc. (RPHM)

Role
Director
Signature
/s/ Vineet R. Jindal, Attorney-in-Fact
Stock symbol
RPHM
Transactions as of
Jan 20, 2022
Transactions value $
$0
Form type
3
Date filed
1/24/2022, 03:55 PM
Previous filing
Jan 6, 2022
Next filing
Jan 24, 2022

No securities are beneficially owned.